Natixis Advisors, L.P. Bio Rad Laboratories, Inc. Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 41,323 shares of BIO stock, worth $13.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

41,323

Previous 33,246 24.29%

Holding current value

$13.2 Million

Previous $9.08 Million 52.27%

% of portfolio

0.03%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$263.97 - $344.64 $2.13 Million - $2.78 Million	8,077 Added 24.29%	41,323 $13.8 Million
Q2 2024 Aug 01, 2024	BUY	$268.26 - $339.48 $1.49 Million - $1.89 Million	5,564 Added 20.1%	33,246 $9.08 Million
Q1 2024 Apr 25, 2024	BUY	$304.11 - $351.99 $2.11 Million - $2.44 Million	6,938 Added 33.45%	27,682 $9.57 Million
Q4 2023 Feb 06, 2024	BUY	$269.37 - $365.04 $849,054 - $1.15 Million	3,152 Added 17.92%	20,744 $6.7 Million
Q3 2023 Nov 13, 2023	BUY	$350.25 - $422.63 $2.13 Million - $2.57 Million	6,082 Added 52.84%	17,592 $6.31 Million
Q2 2023 Aug 15, 2023	BUY	$359.49 - $486.4 $4.14 Million - $5.6 Million	11,510 New	11,510 $4.36 Million
Q2 2021 Aug 12, 2021	SELL	$576.64 - $649.04 $6.77 Million - $7.62 Million	-11,743 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$547.01 - $662.35 $261,470 - $316,603	-478 Reduced 3.91%	11,743 $6.71 Million
Q4 2020 Feb 12, 2021	SELL	$510.68 - $643.45 $293,130 - $369,340	-574 Reduced 4.49%	12,221 $7.12 Million
Q3 2020 Nov 12, 2020	BUY	$454.43 - $535.6 $116,334 - $137,113	256 Added 2.04%	12,795 $6.6 Million
Q2 2020 Aug 11, 2020	BUY	$334.87 - $493.06 $4.2 Million - $6.18 Million	12,539 New	12,539 $5.66 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.3M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $7.89B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Bio Rad Laboratories, Inc. Transaction History